Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2001
12/20/2001WO2001096310A1 Dihydrostilbene alkanoic acid derivatives useful as vitronectin antagonists
12/20/2001WO2001096308A1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof
12/20/2001WO2001096305A1 Serine protease inhibitors
12/20/2001WO2001096304A1 Serine protease inhibitors
12/20/2001WO2001096303A1 Serine protease inhibitors
12/20/2001WO2001096302A1 Piperidines for use as orexin receptor antagonists
12/20/2001WO2001096300A1 Growth hormone secretagogues
12/20/2001WO2001096299A2 Indole derivatives and their use as 15-lipoxygenase inhibitors
12/20/2001WO2001096297A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
12/20/2001WO2001096296A1 Serine protease inhibitors
12/20/2001WO2001096295A2 2-cyanopyrrolidine derivatives and their use as medicaments
12/20/2001WO2001095911A1 Protease inhibitors
12/20/2001WO2001095858A2 Piperazinedione compounds
12/20/2001WO2001095856A2 Urea derivative useful as an anti-cancer agent and process for preparing same
12/20/2001WO2001087838A8 Cyclohexane derivatives and their use as therapeutic agents
12/20/2001WO2001016108A3 Bicyclic androgen and progesterone receptor modulator compounds and methods
12/20/2001WO2000072834A9 Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property
12/20/2001WO1999019304A3 Alpha-alkylthio substituted pyrimidine ethers and thioethers as viral reverse transcriptase inhibitors
12/20/2001US20010053854 Pesticidal compounds and compositions
12/20/2001US20010053853 Alkanoic acid derivative; integrin receptor antagonist
12/20/2001US20010053851 Antidiabetic agents
12/20/2001US20010053788 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity
12/20/2001US20010053779 Antiinflammatory agents; respiratory system disorders
12/20/2001US20010052500 Adding a chelating agent continuously to a semiconductor manufacturing process waste stream containing a metal residue to form a metal complex with at least a portion of the metal residue, and removing the metal complex
12/20/2001DE10029285A1 New 3-(anilino-methylidene)-2-indolinone derivatives, are kinase inhibitors and cell proliferation inhibitors, useful e.g. for treating tumors, metastasis, rheumatoid arthritis or psoriasis
12/20/2001CA2719176A1 2-cyanopyrrolidine derivatives and their use as medicaments
12/20/2001CA2412618A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
12/20/2001CA2412353A1 Protease inhibitors
12/20/2001CA2412216A1 Lactam inhibitors of factor xa and method
12/20/2001CA2412010A1 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines
12/20/2001CA2411805A1 Serine protease inhibitors
12/20/2001CA2411798A1 Serine protease inhibitors
12/20/2001CA2411116A1 Indole derivatives and their use as 15-lipoxygenase inhibitors
12/19/2001EP1164134A1 Benzimidazole compounds and their use as modulators of the GABA A receptor complex
12/19/2001EP1164132A2 Crystalline magnesium omeprazole
12/19/2001EP1163239A1 Modified amino-acid amides as cgrp antagonists
12/19/2001EP1163238A1 Chemokine recpetor binding heterocyclic compounds
12/19/2001EP1163237A1 Amide derivatives
12/19/2001EP1163236A1 Aromatic heterocyclic compounds as anti-inflammatory agents
12/19/2001EP1163228A1 Quinazolines and therapeutic use thereof
12/19/2001EP1163227A1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them
12/19/2001EP1163225A1 Compounds and methods for modulation of estrogen receptors
12/19/2001EP1163224A1 N-[2-hydroxy-3-(1-piperidinyl)propoxy]pyridine-1-oxide-3-carboximidoyl chloride and its use in the treatment of insulin resistance
12/19/2001EP1163221A1 Sulfonamide derivatives as 5ht7 receptor antagonists
12/19/2001EP1163212A1 Amide derivatives
12/19/2001EP1094816A4 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/19/2001EP0847391B1 Aromatic compounds and pharmaceutical compositions containing them
12/19/2001EP0785794B1 Enteric coated compositions of 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity
12/19/2001EP0639080B1 Non-azo naphthalimide dyes and use as alkylating agents
12/19/2001CN1327444A Alpha 1 beta-adrenergic receptor antagonists
12/19/2001CN1327443A Substituted anilides
12/19/2001CN1076351C Benzene derivatives substituted by heterocycles and herbicides
12/18/2001USRE37478 1-(arylthioalkyl, arylaminoalkyl, or arylmethylenealkyl)-4-(heteroaryl)piperazines and related compounds useful as antipsychotics and analgesics
12/18/2001US6331640 Diaminopropionic acid derivatives
12/18/2001US6331639 By reacting a 3-((alkyl, alkoxy, phenyl or heteroaryl)carbonylamino)thiophene with a ketone in the presence of an acid and reducing the reaction mixture; agricultural fungicides
12/18/2001US6331634 Process for preparing 2-alkyl-3-aminothiophene derivative and 3-aminothiophene derivative
12/18/2001US6331630 Dimeric arylisoquinoline alkaloids and derivatives thereof
12/18/2001US6331545 Heterocycyclic piperidines as modulators of chemokine receptor activity
12/18/2001US6331543 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
12/18/2001US6331542 Protease inhibitors
12/18/2001US6331541 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
12/18/2001US6331537 Treating neurological disorders in animals
12/18/2001CA2213815C Pyrrolidinyl hydroxamic acid compounds and their production process
12/18/2001CA2178161C Indole derivatives
12/13/2001WO2001094341A1 Quinazoline derivatives for the treatment of tumours
12/13/2001WO2001094340A1 Heterocyclic hydrazones for use as anti-cancer agents
12/13/2001WO2001094339A1 Substituted pyridine herbicides
12/13/2001WO2001094338A1 Admantane derivatives
12/13/2001WO2001094319A1 Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors
12/13/2001WO2001094317A2 Method for synthesis of substituted azole libraries
12/13/2001WO2001094312A2 Indolinone derivatives as protein kinase/phosphatase inhibitors
12/13/2001WO2001093682A1 N-phenyl-4-(4-pyridyl)-2-pyrimidineamine derivatives
12/13/2001WO2001045637A3 Novel 4(piperazinyl (8-quinolinyl)metyl)benzamides
12/13/2001WO2001044200A3 Selective neurokinin antagonists
12/13/2001WO2001044194A3 Propanoic acid derivatives as integrin inhibitors
12/13/2001WO2001042787A3 Immunoassay for neonicotinyl insecticides
12/13/2001WO2001037820A3 Ionizable indolinone derivatives and their use as ptk ligands
12/13/2001WO2001036660A3 Transition metal complexes attached to a polymer via a flexible chain
12/13/2001WO2001025219A3 Piperazine compounds
12/13/2001US20010051730 Glycoprotein antagonist, inhibitor of blood platelet aggregation and fibrinogen binding
12/13/2001US20010051727 Process for the preparation of chemical compounds
12/13/2001US20010051726 Method for producing 2-sulfonylpyridine derivatives and method for producing 2- { [ (2-pyridyl) methyl] thio} -1H-benzimidazole derivatives
12/13/2001US20010051718 Reacting a 3 substituted 2-amino-pyridine with N-methyl-1-phenyl-2,2'-iminodiethyl halide, then adding ring closing agent to form mirtazepine; antidepressant
12/13/2001US20010051634 Sodium-hydrogen exchanger type 1 inhibitor
12/13/2001US20010051627 Substituted 2-(4-piperidyl)-4(3H)-quinazolinones and 2-(4-piperidyl)- 4(3H)-azaquinazolinones
12/13/2001US20010051620 Tricyclic protein kinase inhibitors
12/13/2001CA2411351A1 Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors
12/13/2001CA2410509A1 Indolinone derivatives as protein kinase/phosphatase inhibitors
12/13/2001CA2409877A1 N-phenyl-4-(4-pyridyl)-2-pyrimidineamine derivatives
12/12/2001EP1162201A2 Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives
12/12/2001EP1162196A1 Fused-ring compounds and use thereof as drugs
12/12/2001EP1161429A2 Heterocyclic compounds as adenosine deaminase inhibitors
12/12/2001EP1161422A1 Amine derivatives as protease inhibitors
12/12/2001EP1161419A1 Spirocyclic ketones and their use as tachykinin antagonists
12/12/2001EP1161415A2 N-cyanomethylamides as protease inhibitors
12/12/2001EP1161240A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
12/12/2001EP0938471B1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
12/12/2001EP0785787B1 Use of 1,5-benzodiazepine derivatives for the control of gastric emptying in patients with non-insulin dependent diabetes mellitus
12/12/2001EP0772597B1 3,4-substituted pyrazoles for the treatment of inflammation
12/12/2001EP0723540B1 Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
1 ... 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 ... 1080